C3 ( CTHR ) Diamond in the rough? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough?

CTHR 0.400

+263.6%

Oct 31 12:16 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Leslie S. Feinberg who wrote (37)	12/31/1997 1:28:00 PM
From: Ceebs Hartmann	Read Replies (1) of 226

I bought some today. Think it is a great buy here down on fairly light volume. Think this company has potential to totally change diamond business and with a market cap of $79 million I think it is a great buy. Several recent stories on ABC and Discovery exposing that gemologists are unable to tell the difference. If nothing else market for testing device should be huge and immediate. Lastly, insider buying -- Insider Buys C3 INC. Stock 12/17/97 Select Federal Filings Newswires (Copyright (c) 1997, Dow Jones & Company, Inc.) FORM 4 ISSUER: C3 INC. SYMBOL: CTHR FILER: SYKES OLLIN B TITLE: Director PURCHASED: 11/14/97-11/19/97 22,300 14.63-15.00 OWNERSHIP: 103,512 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - (END) FEDERAL FILINGS-DOW JONES NEWS 12-17-97 05:17

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next